|
- IRMS - Nicolae Testemitanu SUMPh
- 1. COLECȚIA INSTITUȚIONALĂ
- MATERIALE ALE CONFERINȚELOR ȘTIINȚIFICE
- Conferinţa ştiinţifică anuală "Cercetarea în biomedicină și sănătate: calitate, excelență și performanță", 2022
- Conferinţa ştiinţifică anuală "Cercetarea în biomedicină și sănătate: calitate, excelență și performanță", 19-21 octombrie, 2022: Culegere de postere
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/22370
Title: | Pathogenetic diversity of the immune disturbances in patients with pulmonary drug susceptible and drug resistant tuberculosis |
Authors: | Niguleanu, Adriana Lesnic, Evelina Privalova, Elena Ghinda, Serghei |
Keywords: | tuberculosis;cell-mediated immune response;natural resistance;humoral immunity |
Issue Date: | 2022 |
Publisher: | Universitatea de Stat de Medicină şi Farmacie "Nicolae Testemiţanu" din Republica Moldova |
Citation: | NIGULEANU, Adriana, LESNIC, Evelina, PRIVALOVA, Elena, GHINDA, Serghei. Pathogenetic diversity of the immune disturbances in patients with pulmonary drug susceptible and drug resistant tuberculosis: [poster]. In: Conferinţa ştiinţifică anuală "Cercetarea în biomedicină și sănătate: calitate, excelență și performanță", 19-21 octombrie 2022: culegere de postere electronice. 2022, p. 115. |
Abstract: | Introduction.
The immune response to M. tuberculosis infection
consists mainly in the activation of the cell-mediated immune response (CIR). Natural
resistance (NR) and humoral immunity (HI)
contribute to a long-lasting immune resistance to
reinfection and reactivation of latent infection.
Purpose.
Assessment of the pathogenetic diversity of
immune disorders (ID) in serum in patients with
pulmonary susceptible tuberculosis (S-TB) and
MDR-TB.
Material and methods.
Indicators of CIR (CD3+), NR (phagocytic number), and HI (CD19 +) were
determined in 36 healthy individuals (control group-CG), 57 new cases
with S-TB (study group 1-SG1) and 72 new cases of MDR-TB (study group
2-SG2). The average was reported to the CG which was the reference value,
%. Range 1-33% of the reference value in CG considered the 1st degree of
ID, 34-66% - the 2nd degree ID, >66% -the 3rd degree ID, as positiveimmune overactivity (IOA) and negative-immune deficiency (ID).
Results.
Indices of CIR showed in the SG1 the cell-mediated immune defficiencies
(CID) in 23 (41%) cases all of the 1st degree ID, in the SG2- CID of the 1st
degree was in 60 (82%) and of 2nd degree CID - in 10 (18%) of cases. In
the SG1 the CID was established in 32 (91%) and HI deficiencies (HID)
in 3 (9%). In the SG2 the CID was in 26 (90%), HID in 6 (10%) and NR
deficiencies (NRD) in 8(23%) of cases. SG1 the 1st degree IOA was
detected in 26(43%), 2nd degree 11(31%) and 3rd degree 9 (26%) cases.
In SG2 the 1st degree IOA was established in 10 (16%), 2 nd degree in 22
(36%) and 3 rd degree in 29 (53%) of cases.
Conclusion. The deficiencies of the CIR were more frequently,
established in patients with MDR-TB, associated with a higher rate of
NRD and HID and a higher degree of IOA. |
metadata.dc.relation.ispartof: | Conferinţa ştiinţifică anuală "Cercetarea în biomedicină și sănătate: calitate, excelență și performanță", 2022 |
URI: | https://conferinta.usmf.md/wp-content/uploads/culegere_de_postere_2022.pdf http://repository.usmf.md/handle/20.500.12710/22370 |
Appears in Collections: | Conferinţa ştiinţifică anuală "Cercetarea în biomedicină și sănătate: calitate, excelență și performanță", 19-21 octombrie, 2022: Culegere de postere
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|